Literature DB >> 8845746

Complement factor D, a novel serine protease.

J E Volanakis1, S V Narayana.   

Abstract

Factor D is unique among serine proteases in that it requires neither enzymatic cleavage for expression of proteolytic activity nor inactivation by a serpin for its control. Regulation of factor D activity is instead attained by a novel mechanism that depends on reversible conformational changes for expression and control of catalytic activity. These conformational changes are believed to be induced by the single natural substrate, C3bB, and to result in realignment of the catalytic triad, the specificity pocket, and the nonspecific substrate binding site, all of which have atypical conformations. Mutational studies have defined structural determinants responsible for these unique structural features of factor D and for the resultant low reactivity with synthetic esters.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8845746      PMCID: PMC2143395          DOI: 10.1002/pro.5560050401

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  14 in total

1.  Secretion of functional papain precursor from insect cells. Requirement for N-glycosylation of the pro-region.

Authors:  T Vernet; D C Tessier; C Richardson; F Laliberté; H E Khouri; A W Bell; A C Storer; D Y Thomas
Journal:  J Biol Chem       Date:  1990-09-25       Impact factor: 5.157

Review 2.  How do serine proteases really work?

Authors:  A Warshel; G Naray-Szabo; F Sussman; J K Hwang
Journal:  Biochemistry       Date:  1989-05-02       Impact factor: 3.162

3.  Isolation of complement protein D from urine of patients with Fanconi's syndrome.

Authors:  J E Volanakis; K J Macon
Journal:  Anal Biochem       Date:  1987-05-15       Impact factor: 3.365

4.  Comparison of the active site stereochemistry and substrate conformation in -chymotrypsin and subtilisin BPN'.

Authors:  C S Wright
Journal:  J Mol Biol       Date:  1972-06-14       Impact factor: 5.469

5.  Structure of subtilisin BPN' at 2.5 angström resolution.

Authors:  C S Wright; R A Alden; J Kraut
Journal:  Nature       Date:  1969-01-18       Impact factor: 49.962

6.  Quantitation of complement factor D in human serum by a solid-phase radioimmunoassay.

Authors:  S R Barnum; M A Niemann; J F Kearney; J E Volanakis
Journal:  J Immunol Methods       Date:  1984-03-16       Impact factor: 2.303

7.  Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue.

Authors:  R T White; D Damm; N Hancock; B S Rosen; B B Lowell; P Usher; J S Flier; B M Spiegelman
Journal:  J Biol Chem       Date:  1992-05-05       Impact factor: 5.157

8.  Recombinant and native zymogen forms of human complement factor D.

Authors:  Y Yamauchi; J W Stevens; K J Macon; J E Volanakis
Journal:  J Immunol       Date:  1994-04-01       Impact factor: 5.422

9.  Production and interferon-gamma-mediated regulation of complement component C2 and factors B and D by the astroglioma cell line U105-MG.

Authors:  S R Barnum; Y Ishii; A Agrawal; J E Volanakis
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

10.  Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes.

Authors:  K Whaley
Journal:  J Exp Med       Date:  1980-03-01       Impact factor: 14.307

View more
  52 in total

1.  New structural motifs on the chymotrypsin fold and their potential roles in complement factor B.

Authors:  H Jing; Y Xu; M Carson; D Moore; K J Macon; J E Volanakis; S V Narayana
Journal:  EMBO J       Date:  2000-01-17       Impact factor: 11.598

2.  The insect immune protein scolexin is a novel serine proteinase homolog.

Authors:  C M Finnerty; P A Karplus; R R Granados
Journal:  Protein Sci       Date:  1999-01       Impact factor: 6.725

3.  Identification of genetic networks.

Authors:  Momiao Xiong; Jun Li; Xiangzhong Fang
Journal:  Genetics       Date:  2004-02       Impact factor: 4.562

4.  The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation.

Authors:  M Harboe; G Ulvund; L Vien; M Fung; T E Mollnes
Journal:  Clin Exp Immunol       Date:  2004-12       Impact factor: 4.330

5.  Manduca sexta hemolymph proteinase 21 activates prophenoloxidase-activating proteinase 3 in an insect innate immune response proteinase cascade.

Authors:  Maureen J Gorman; Yang Wang; Haobo Jiang; Michael R Kanost
Journal:  J Biol Chem       Date:  2007-02-22       Impact factor: 5.157

6.  Essential role of complement mannose-binding lectin-associated serine proteases-1/3 in the murine collagen antibody-induced model of inflammatory arthritis.

Authors:  Nirmal K Banda; Minoru Takahashi; Brandt Levitt; Magdalena Glogowska; Jessica Nicholas; Kazue Takahashi; Gregory L Stahl; Teizo Fujita; William P Arend; V Michael Holers
Journal:  J Immunol       Date:  2010-09-24       Impact factor: 5.422

7.  The structure of C2b, a fragment of complement component C2 produced during C3 convertase formation.

Authors:  Vengadesan Krishnan; Yuanyuan Xu; Kevin Macon; John E Volanakis; Sthanam V L Narayana
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-02-20

8.  Discovery and Design of First Benzylamine-Based Ligands Binding to an Unlocked Conformation of the Complement Factor D.

Authors:  Anna Vulpetti; Nils Ostermann; Stefan Randl; Taeyoung Yoon; Aengus Mac Sweeney; Frederic Cumin; Edwige Lorthiois; Simon Rüdisser; Paul Erbel; Jürgen Maibaum
Journal:  ACS Med Chem Lett       Date:  2018-04-24       Impact factor: 4.345

9.  Roles of adipocytes and fibroblasts in activation of the alternative pathway of complement in inflammatory arthritis in mice.

Authors:  William P Arend; Gaurav Mehta; Alexandra H Antonioli; Minoru Takahashi; Kazue Takahashi; Gregory L Stahl; V Michael Holers; Nirmal K Banda
Journal:  J Immunol       Date:  2013-05-06       Impact factor: 5.422

Review 10.  Complement: an overview for the clinician.

Authors:  Juan Carlos Varela; Stephen Tomlinson
Journal:  Hematol Oncol Clin North Am       Date:  2015-04-04       Impact factor: 3.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.